The effects of haloperidol treatment on the distribution of NK1 receptor immunoreactive neurons in guinea-pig brain

Neurosci Lett. 2005 Jul;383(1-2):155-9. doi: 10.1016/j.neulet.2005.04.012. Epub 2005 Apr 20.

Abstract

Previous studies have observed increased tachykinin NK(1) receptor immunoreactivity (NK(1)-IR) in the prefrontal cortex in subjects with schizophrenia. Since the subjects were medicated the possibility of a treatment effect could not be excluded. Thus, the present study was undertaken to determine the effect of chronic treatment with the antipsychotic drug, haloperidol, on the distribution of NK(1)-IR neurons in the guinea-pig brain. Guinea pigs were treated each day for 21 days with either haloperidol (1mg/kg) or vehicle and the brains were then processed for immunohistochemistry using an NK(1) receptor-specific polyclonal antibody. NK(1)-IR neurons and fibres were abundant in the forebrain cortex and caudate putamen and more sparsely distributed in a number of other brain regions. The relative density of NK(1)-IR neurons was significantly increased in the forebrain cortex, but not in the caudate putamen in guinea pigs treated with haloperidol. This study has shown that haloperidol causes region-specific changes to the density of NK(1)-IR neurons. Whether these changes are related to the therapeutic effects or to the side effects of haloperidol in individuals with schizophrenia, remains to be determined.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antipsychotic Agents / pharmacology*
  • Brain / cytology*
  • Brain / drug effects
  • Cell Count / methods
  • Dopamine Agonists / pharmacology
  • Drug Interactions
  • Female
  • Gene Expression Regulation / drug effects
  • Guinea Pigs
  • Haloperidol / pharmacology*
  • Immunohistochemistry / methods
  • Male
  • Neurons / drug effects*
  • Neurons / metabolism
  • Quinpirole / pharmacology
  • Receptors, Neurokinin-1 / metabolism*
  • Tissue Distribution / drug effects

Substances

  • Antipsychotic Agents
  • Dopamine Agonists
  • Receptors, Neurokinin-1
  • Quinpirole
  • Haloperidol